Illustration of Altered Glucose Dependency in Drug-Resistant Cancer Cells

Primary tumors are metabolically dependent on the Warburg pathway for fast energy and carbon sources, and several oncogenic activations feed into it. The first line of cancer therapy with multiple pathway blockers can inhibit the oncogenic activations, but in turn, cancer cells reprogram themselves, and dependency upon the Warburg pathway shifts to other metabolic pathways. Moreover, the theory of CSC’s self-renewal is now a popular area of study, which might be a factor that controls tumor recurrence. The evolved drug-resistant tumors are more aggressive and do metastasize to distant sites in the human body and form secondary tumors. CSC: cancer stem cells, “↑” indicates upregulation and “?” indicates the probable pathway activation (This figure was drawn using the Bio Render app).
Illustration of Altered Glucose Dependency in Drug-Resistant Cancer Cells

Publication

The Illustration of Altered Glucose Dependency in Drug-Resistant Cancer Cells. (2023) Kausik Bishayee, et al. Int J Mol Sci. 2023 Sep;24(18):13928. Figure: F1.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates (KRas,HIF1a,MYC/MYCN,PI3K-AKT)1 HIF1A ncbigene_symbol HIF1A 3091
Homo sapiens Primates (KRas,HIF1a,MYC/MYCN,PI3K-AKT)1 MYC ncbigene_symbol MYC 4609
Homo sapiens Primates (KRas,HIF1a,MYC/MYCN,PI3K-AKT)1 MYCN ncbigene_symbol MYCN 4613
Homo sapiens Primates (KRas, KRAS ncbigene_symbol KRAS 3845
Homo sapiens Primates (KRas, KRAS ncbigene_synonym NRAS 4893

Chemical mentions

Word Match MeSH Name ChEBI

Disease mentions

Word Match MeSH Name DOID
Primary tumor NA mesh:D009369
tumor NA mesh:D009369